Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeSales of Property, Plant and EquipmentShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Generation Bio (GBIO) Cash from Investing Activities (2021 - 2025)

Historic Cash from Investing Activities for Generation Bio (GBIO) over the last 5 years, with Q3 2025 value amounting to $25.5 million.

  • Generation Bio's Cash from Investing Activities rose 10088.13% to $25.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $113.7 million, marking a year-over-year increase of 40924.72%. This contributed to the annual value of $94.5 million for FY2024, which is 107472.67% up from last year.
  • Per Generation Bio's latest filing, its Cash from Investing Activities stood at $25.5 million for Q3 2025, which was up 10088.13% from $15.0 million recorded in Q2 2025.
  • In the past 5 years, Generation Bio's Cash from Investing Activities registered a high of $113.5 million during Q1 2021, and its lowest value of -$158.7 million during Q2 2022.
  • For the 5-year period, Generation Bio's Cash from Investing Activities averaged around $6.8 million, with its median value being $7.2 million (2021).
  • Its Cash from Investing Activities has fluctuated over the past 5 years, first crashed by 41597.59% in 2022, then soared by 377210.03% in 2024.
  • Generation Bio's Cash from Investing Activities (Quarter) stood at $7.2 million in 2021, then plummeted by 356.75% to -$18.4 million in 2022, then surged by 89.6% to -$1.9 million in 2023, then skyrocketed by 3772.1% to $70.3 million in 2024, then tumbled by 63.68% to $25.5 million in 2025.
  • Its Cash from Investing Activities stands at $25.5 million for Q3 2025, versus $15.0 million for Q2 2025 and $3.0 million for Q1 2025.